标题
Alternatives to antibiotics in an era of difficult-to-treat resistance: new insights
作者
关键词
-
出版物
Expert Review of Clinical Pharmacology
Volume -, Issue -, Pages 1-8
出版商
Informa UK Limited
发表日期
2019-05-16
DOI
10.1080/17512433.2019.1619454
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Perceived differences between intensivists and infectious diseases consultants facing antimicrobial resistance: a global cross-sectional survey
- (2019) Jordi Rello et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- One step closer to precision medicine for infectious diseases
- (2019) Mathias W Pletz et al. LANCET INFECTIOUS DISEASES
- CAL02, a novel antitoxin liposomal agent, in severe pneumococcal pneumonia: a first-in-human, double-blind, placebo-controlled, randomised trial
- (2019) Pierre-François Laterre et al. LANCET INFECTIOUS DISEASES
- Safety and tolerability of a single administration of AR-301, a human monoclonal antibody, in ICU patients with severe pneumonia caused by Staphylococcus aureus: first-in-human trial
- (2018) Bruno François et al. INTENSIVE CARE MEDICINE
- KB001-A, a novel anti-inflammatory, found to be safe and well-tolerated in cystic fibrosis patients infected with Pseudomonas aeruginosa
- (2018) R. Jain et al. Journal of Cystic Fibrosis
- Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis
- (2018) Evelina Tacconelli et al. LANCET INFECTIOUS DISEASES
- Development of Phage Lysins as Novel Therapeutics: A Historical Perspective
- (2018) Vincent Fischetti Viruses-Basel
- Effects of Phage Endolysin SAL200 Combined with Antibiotics on Staphylococcus aureus Infection
- (2018) Nak-Hyun Kim et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Phase 1 study of MEDI3902, an investigational anti–Pseudomonas aeruginosa PcrV and Psl bispecific human monoclonal antibody, in healthy adults
- (2018) S.O. Ali et al. CLINICAL MICROBIOLOGY AND INFECTION
- A global priority list of the TOp TEn resistant Microorganisms (TOTEM) study at intensive care: a prioritization exercise based on multi-criteria decision analysis
- (2018) Jordi Rello et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Efficacy and tolerability of a cocktail of bacteriophages to treat burn wounds infected by Pseudomonas aeruginosa (PhagoBurn): a randomised, controlled, double-blind phase 1/2 trial
- (2018) Patrick Jault et al. LANCET INFECTIOUS DISEASES
- The disparate effects of bacteriophages on antibiotic-resistant bacteria
- (2018) Clara Torres-Barceló Emerging Microbes & Infections
- Treatment with allogeneic mesenchymal stromal cells for moderate to severe acute respiratory distress syndrome (START study): a randomised phase 2a safety trial
- (2018) Michael A Matthay et al. Lancet Respiratory Medicine
- Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection
- (2017) Mark H. Wilcox et al. NEW ENGLAND JOURNAL OF MEDICINE
- SA4Ag, a 4-antigen Staphylococcus aureus vaccine, rapidly induces high levels of bacteria-killing antibodies
- (2017) Elizabeth Begier et al. VACCINE
- Disarming Staphylococcus aureus from destroying human cells by simultaneously neutralizing six cytotoxins with two human monoclonal antibodies
- (2017) Harald Rouha et al. Virulence
- Bacteriophages for treating urinary tract infections in patients undergoing transurethral resection of the prostate: a randomized, placebo-controlled, double-blind clinical trial
- (2017) Lorenz Leitner et al. BMC Urology
- Safety and Immunogenicity of a Parenterally Administered, Structure-Based Rationally Modified Recombinant Staphylococcal Enterotoxin B Protein Vaccine, STEBVax
- (2016) Wilbur H. Chen et al. Clinical and Vaccine Immunology
- Do we need new antibiotics?
- (2016) J.-M. Rolain et al. CLINICAL MICROBIOLOGY AND INFECTION
- Characterization of a Bacteriophage-Derived Murein Peptidase for Elimination of Antibiotic-Resistant Staphylococcus aureus
- (2016) Ruth Keary et al. CURRENT PROTEIN & PEPTIDE SCIENCE
- Vaccine against toxic shock syndrome in a first-in-man clinical trial
- (2016) Andreas Roetzer et al. Expert Review of Vaccines
- Potential of combination therapy of endolysin MR-10 and minocycline in treating MRSA induced systemic and localized burn wound infections in mice
- (2016) Shivani Chopra et al. INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY
- Alternatives to antibiotics—a pipeline portfolio review
- (2016) Lloyd Czaplewski et al. LANCET INFECTIOUS DISEASES
- Safety and immunogenicity of a recombinant Staphylococcus aureus α-toxoid and a recombinant Panton-Valentine leukocidin subunit, in healthy adults
- (2016) Michael L. Landrum et al. Human Vaccines & Immunotherapeutics
- Will 10 Million People Die a Year due to Antimicrobial Resistance by 2050?
- (2016) Marlieke E. A. de Kraker et al. PLOS MEDICINE
- Structural and Enzymatic Characterization of ABgp46, a Novel Phage Endolysin with Broad Anti-Gram-Negative Bacterial Activity
- (2016) Hugo Oliveira et al. Frontiers in Microbiology
- What if there were no new antibiotics? A look at alternatives
- (2016) Jordi Rello et al. Expert Review of Clinical Pharmacology
- MEDI4893* Promotes Survival and Extends the Antibiotic Treatment Window in a Staphylococcus aureus Immunocompromised Pneumonia Model
- (2015) L. Hua et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Liposomes as novel anti-infectives targeting bacterial virulence factors?
- (2015) Samareh Azeredo da Silveira et al. Expert Review of Anti-Infective Therapy
- Mesenchymal stem (stromal) cells for treatment of ARDS: a phase 1 clinical trial
- (2015) Jennifer G Wilson et al. Lancet Respiratory Medicine
- Quality-Controlled Small-Scale Production of a Well-Defined Bacteriophage Cocktail for Use in Human Clinical Trials
- (2009) Maya Merabishvili et al. PLoS One
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started